Providence Therapeutics Inc. — Form D
Providence Therapeutics Inc. of CALGARY, A0, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-24. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-07-24
- Form: D
- Accession: 0001681648-20-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $3.5M
- Investors: 18
- Date of first sale: 2019-08-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-371762
Issuer
- Name: Providence Therapeutics Inc.
- CIK: 0001681648
- Entity type: Corporation
- Jurisdiction: ALBERTA, CANADA
- Incorporated: 2015
- Address: 140 SUNHAVEN CLOSE SE, CALGARY, A0, T2X 2V9
- Phone: 403-909-4532
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Scott Leary | Director | San Diego, CA |
| Bradley Sorenson | Director | Calgary, A0 |
| Darlene Haslam | Executive Officer | Calgary, A0 |
| Kenneth Hughes | Executive Officer | Calgary, A0 |
| Scott Leary | Executive Officer | San Diego, CA |
| Eric Marcusson | Executive Officer | San Francisco, CA |
| Natalia Orozco | Executive Officer | Toronto, A6 |
| Bradley Sorenson | Executive Officer | Calgary, A0 |
| Eric Gates Marcusson | Executive Officer | San Francisco, CA |
| Nicholas M Dean | Director | Encinitas, CA |
| Nicholas M Dean | Executive Officer | Encinitas, CA |
| Bradley Thomas Sorenson | Director | Calgary, A0 |
| Bradley Thomas Sorenson | Executive Officer | Calgary, A0 |
Other filings by this issuer (3)
More